Unmasked renal impairment and prolonged hyperkalemia after unilateral adrenalectomy for primary aldosteronism coexisting with primary hyperparathyroidism

report of a case

Yatsuka Hibi, Nobuki Hayakawa, Midori Hasegawa, Kimio Ogawa, Yoshimi Shimizu, Masahiro Shibata, Chikara Kagawa, Yutaka Mizuno, Yukio Yuzawa, Mitsuyasu Itoh, Katsumi Iwase

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

We herein report the case of a patient with critical hyperkalemia after unilateral adrenalectomy (ADX) for aldosterone-producing adenomas, which were coexisting with primary hyperparathyroidism. A right adrenal tumor oversecreting mineral corticoid was identified in a 62-year-old female whose kidney function had been impaired due to primary hyperaldosteronism and hyperparathyroidism. The ADX improved her hypertension with normalization of the plasma aldosterone concentration, but without adequately increasing her plasma renin activity. Her eGFR further decreased postoperatively, hyperkalemia appeared and the serum potassium level rose to 6.3 mEq/L at 3 months after ADX. Then, treatment with calcium polystyrene sulfonate jelly was started. Eight months after ADX, a left lower parathyroidectomy was performed, and the serum calcium and intact parathyroid hormone levels decreased to the normal range. The hyperkalemia was difficult to control within 20 months postoperatively without treatment with calcium polystyrene sulfonate jelly or hydrocortisone. This suggests that unmasking the renal impairment and relative hypoaldosteronism after ADX might induce critical hyperkalemia.

Original languageEnglish
Pages (from-to)241-246
Number of pages6
JournalSurgery Today
Volume45
Issue number2
DOIs
Publication statusPublished - 01-01-2015

Fingerprint

Hyperkalemia
Hyperaldosteronism
Primary Hyperparathyroidism
Adrenalectomy
Kidney
Aldosterone
Hypoaldosteronism
Parathyroidectomy
Glandular and Epithelial Neoplasms
Parathyroid Hormone
Serum
Renin
Adenoma
Minerals
Hydrocortisone
Potassium
Adrenal Cortex Hormones
Reference Values
Hypertension
Calcium

All Science Journal Classification (ASJC) codes

  • Surgery

Cite this

Hibi, Yatsuka ; Hayakawa, Nobuki ; Hasegawa, Midori ; Ogawa, Kimio ; Shimizu, Yoshimi ; Shibata, Masahiro ; Kagawa, Chikara ; Mizuno, Yutaka ; Yuzawa, Yukio ; Itoh, Mitsuyasu ; Iwase, Katsumi. / Unmasked renal impairment and prolonged hyperkalemia after unilateral adrenalectomy for primary aldosteronism coexisting with primary hyperparathyroidism : report of a case. In: Surgery Today. 2015 ; Vol. 45, No. 2. pp. 241-246.
@article{dc9931a2319548feacfccaf22d33416e,
title = "Unmasked renal impairment and prolonged hyperkalemia after unilateral adrenalectomy for primary aldosteronism coexisting with primary hyperparathyroidism: report of a case",
abstract = "We herein report the case of a patient with critical hyperkalemia after unilateral adrenalectomy (ADX) for aldosterone-producing adenomas, which were coexisting with primary hyperparathyroidism. A right adrenal tumor oversecreting mineral corticoid was identified in a 62-year-old female whose kidney function had been impaired due to primary hyperaldosteronism and hyperparathyroidism. The ADX improved her hypertension with normalization of the plasma aldosterone concentration, but without adequately increasing her plasma renin activity. Her eGFR further decreased postoperatively, hyperkalemia appeared and the serum potassium level rose to 6.3 mEq/L at 3 months after ADX. Then, treatment with calcium polystyrene sulfonate jelly was started. Eight months after ADX, a left lower parathyroidectomy was performed, and the serum calcium and intact parathyroid hormone levels decreased to the normal range. The hyperkalemia was difficult to control within 20 months postoperatively without treatment with calcium polystyrene sulfonate jelly or hydrocortisone. This suggests that unmasking the renal impairment and relative hypoaldosteronism after ADX might induce critical hyperkalemia.",
author = "Yatsuka Hibi and Nobuki Hayakawa and Midori Hasegawa and Kimio Ogawa and Yoshimi Shimizu and Masahiro Shibata and Chikara Kagawa and Yutaka Mizuno and Yukio Yuzawa and Mitsuyasu Itoh and Katsumi Iwase",
year = "2015",
month = "1",
day = "1",
doi = "10.1007/s00595-013-0813-0",
language = "English",
volume = "45",
pages = "241--246",
journal = "Surgery Today",
issn = "0941-1291",
publisher = "Springer Japan",
number = "2",

}

Unmasked renal impairment and prolonged hyperkalemia after unilateral adrenalectomy for primary aldosteronism coexisting with primary hyperparathyroidism : report of a case. / Hibi, Yatsuka; Hayakawa, Nobuki; Hasegawa, Midori; Ogawa, Kimio; Shimizu, Yoshimi; Shibata, Masahiro; Kagawa, Chikara; Mizuno, Yutaka; Yuzawa, Yukio; Itoh, Mitsuyasu; Iwase, Katsumi.

In: Surgery Today, Vol. 45, No. 2, 01.01.2015, p. 241-246.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Unmasked renal impairment and prolonged hyperkalemia after unilateral adrenalectomy for primary aldosteronism coexisting with primary hyperparathyroidism

T2 - report of a case

AU - Hibi, Yatsuka

AU - Hayakawa, Nobuki

AU - Hasegawa, Midori

AU - Ogawa, Kimio

AU - Shimizu, Yoshimi

AU - Shibata, Masahiro

AU - Kagawa, Chikara

AU - Mizuno, Yutaka

AU - Yuzawa, Yukio

AU - Itoh, Mitsuyasu

AU - Iwase, Katsumi

PY - 2015/1/1

Y1 - 2015/1/1

N2 - We herein report the case of a patient with critical hyperkalemia after unilateral adrenalectomy (ADX) for aldosterone-producing adenomas, which were coexisting with primary hyperparathyroidism. A right adrenal tumor oversecreting mineral corticoid was identified in a 62-year-old female whose kidney function had been impaired due to primary hyperaldosteronism and hyperparathyroidism. The ADX improved her hypertension with normalization of the plasma aldosterone concentration, but without adequately increasing her plasma renin activity. Her eGFR further decreased postoperatively, hyperkalemia appeared and the serum potassium level rose to 6.3 mEq/L at 3 months after ADX. Then, treatment with calcium polystyrene sulfonate jelly was started. Eight months after ADX, a left lower parathyroidectomy was performed, and the serum calcium and intact parathyroid hormone levels decreased to the normal range. The hyperkalemia was difficult to control within 20 months postoperatively without treatment with calcium polystyrene sulfonate jelly or hydrocortisone. This suggests that unmasking the renal impairment and relative hypoaldosteronism after ADX might induce critical hyperkalemia.

AB - We herein report the case of a patient with critical hyperkalemia after unilateral adrenalectomy (ADX) for aldosterone-producing adenomas, which were coexisting with primary hyperparathyroidism. A right adrenal tumor oversecreting mineral corticoid was identified in a 62-year-old female whose kidney function had been impaired due to primary hyperaldosteronism and hyperparathyroidism. The ADX improved her hypertension with normalization of the plasma aldosterone concentration, but without adequately increasing her plasma renin activity. Her eGFR further decreased postoperatively, hyperkalemia appeared and the serum potassium level rose to 6.3 mEq/L at 3 months after ADX. Then, treatment with calcium polystyrene sulfonate jelly was started. Eight months after ADX, a left lower parathyroidectomy was performed, and the serum calcium and intact parathyroid hormone levels decreased to the normal range. The hyperkalemia was difficult to control within 20 months postoperatively without treatment with calcium polystyrene sulfonate jelly or hydrocortisone. This suggests that unmasking the renal impairment and relative hypoaldosteronism after ADX might induce critical hyperkalemia.

UR - http://www.scopus.com/inward/record.url?scp=84921031488&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84921031488&partnerID=8YFLogxK

U2 - 10.1007/s00595-013-0813-0

DO - 10.1007/s00595-013-0813-0

M3 - Article

VL - 45

SP - 241

EP - 246

JO - Surgery Today

JF - Surgery Today

SN - 0941-1291

IS - 2

ER -